Richard Pzena's position in Pfizer is currently worth $171 Million. That's 0.61% of their equity portfolio (35th largest holding). The first Pfizer trade was made in Q4 2014. Since then Richard Pzena bought shares nineteen more times and sold shares on twenty occasions. The investor's estimated purchase price is $230 Million, resulting in a loss of 26%.